Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 171 | 44 | 44 | 44 | 44 |
| Gross Profit | 171 | 44 | 44 | 44 | 44 |
| Operating Expenses | 25,286 | 22,398 | 12,744 | 11,256 | 7,053 |
| Operating Income | -25,115 | -22,354 | -12,700 | -11,213 | -7,009 |
| Other Income | 2,540 | -71 | 1,074 | -2,770 | -3,676 |
| Pre-tax Income | -22,575 | -22,425 | -11,627 | -13,983 | -10,686 |
| Net Income Continuous | -22,575 | -22,420 | -11,627 | -13,983 | -10,686 |
| Minority Interests | N/A | 0 | 3 | -40 | -57 |
| Net Income | $-22,575 | $-22,430 | $-11,629 | $-13,943 | $-10,628 |
| EPS Basic Total Ops | -0.41 | -0.44 | -0.22 | -0.31 | -0.28 |
| EPS Basic Continuous Ops | -0.41 | -0.43 | -0.22 | -0.32 | -0.28 |
| EPS Diluted Total Ops | -0.41 | -0.44 | -0.22 | -0.31 | -0.28 |
| EPS Diluted Continuous Ops | -0.41 | -0.43 | -0.22 | -0.32 | -0.28 |
| EBITDA(a) | $-24,478 | $-21,706 | $-12,277 | $-10,576 | $-6,578 |